Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwong-Yok Tsang

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cell Death & Disease|September 30, 2016
Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapiesCharli Dominguez, Kwong-Yok Tsang, Claudia Palena
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cellsSixun Yang, Kwong-Yok Tsang, Jeffrey Schlom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptideClaudia Palena, Jeffrey Schlom, Kwong-Yok Tsang
Frontiers in Immunology|December 11, 2023
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapyMassimo Fantini, Philip Martin Arlen, Kwong Yok Tsang
Blood|March 11, 2004
Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cellsClaudia Palena, MingZhu Zhu, Jeffrey Schlom, et al.
Expert Review of Vaccines|January 9, 2004
Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancerPhilip M Arlen, James L Gulley, Kwong-Yok Tsang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigenHiroshi Terasawa, Kwong-Yok Tsang, James Gulley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1Kwong-Yok Tsang, Claudia Palena, James Gulley, et al.
Cancer Research|March 15, 2014
WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transitionDuane H Hamilton, Bruce Huang, Romaine I Fernando, et al.
Leukemia Research|February 4, 2010
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cellsMary T Litzinger, Kenneth A Foon, Kwong-Yok Tsang, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cell Death & Disease|September 30, 2016
Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapiesCharli Dominguez, Kwong-Yok Tsang, Claudia Palena
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cellsSixun Yang, Kwong-Yok Tsang, Jeffrey Schlom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptideClaudia Palena, Jeffrey Schlom, Kwong-Yok Tsang
Frontiers in Immunology|December 11, 2023
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapyMassimo Fantini, Philip Martin Arlen, Kwong Yok Tsang
Blood|March 11, 2004
Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cellsClaudia Palena, MingZhu Zhu, Jeffrey Schlom, et al.
Expert Review of Vaccines|January 9, 2004
Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancerPhilip M Arlen, James L Gulley, Kwong-Yok Tsang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigenHiroshi Terasawa, Kwong-Yok Tsang, James Gulley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1Kwong-Yok Tsang, Claudia Palena, James Gulley, et al.
Cancer Research|March 15, 2014
WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transitionDuane H Hamilton, Bruce Huang, Romaine I Fernando, et al.
Leukemia Research|February 4, 2010
Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cellsMary T Litzinger, Kenneth A Foon, Kwong-Yok Tsang, et al.
Pageof 5